Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Financial Results:
- Gufic BioSciences Ltd reported Revenues for Q1FY24 of ₹195.00 Crores up from ₹165.00 Crore year on year, a rise of 18.18%.
- Total Expenses for Q1FY24 of ₹168.00 Crores up from ₹137.00 Crores year on year, a rise of 22.63%.
- Consolidated Net Profit of ₹21.00 Crores from ₹21.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹2.13, down 1.84% from ₹2.17 in the same quarter of the previous year.